TLP
ISEE

Tri Locum Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Tri Locum Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-106,711
Closed -$2.6M – 83
2023
Q1 		$2.6M Sell
106,711
-136,368
-56% -$2.99M 0.79% 34
2022
Q4 		$5.2M Buy
243,079
+52,482
+28% +$1.12M 2.1% 18
2022
Q3 		$3.42M Buy
+190,597
New +$2.5M 0.94% 31
2022
Q2 		– Sell
-504,371
Closed -$8.49M – 65
2022
Q1 		$8.49M Buy
+504,371
New +$7.45M 3.32% 13
2021
Q4 		– Sell
-377,708
Closed -$6.13M – 56
2021
Q3 		$6.13M Buy
377,708
+280,888
+290% +$3.06M 2.44% 16
2021
Q2 		$611K Buy
+96,820
New +$625K 0.2% 29

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Tri Locum Partners's ISEE Position: Q2 2023 in Review

Tri Locum Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 106,711 shares — an estimated $2.6M sold.

Tri Locum Partners first reported a position in ISEE in Q2 2021 and held it in 6 quarters. The position peaked at $8.49M in Q1 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Tri Locum Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Tri Locum Partners sold 106,711 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $2.6M.
  • Tri Locum Partners first reported a position in IVERIC bio, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Tri Locum Partners's IVERIC bio, Inc. Common Stock position peaked at $8.49M in Q1 2022.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Tri Locum Partners's 13F filing for Q2 2023, filed 14 Aug 2023.